The FDA has sought class-wide safety labeling changes, including dosing information and a new boxed warning for immediate-release opioid pain medications about the serious risks of misuse, abuse, addiction, overdose and death.
from RTT - Biotech http://ift.tt/1SgTJdD
via IFTTT
No comments:
Post a Comment